← All founders and startups

XYLO

Health & biotech · Australia

About XYLO

Xylo Bio is a clinical-stage biotechnology company developing next-generation, non-hallucinogenic neuroplastogens to treat psychiatric and neurological conditions. xylo.bio (Checked automatically: the source page says this)

Industry
Health & biotech xylo.bio (Checked automatically: the source page says this)
Announced
2024-04 xylo.bio (Checked automatically: the source page says this)
Investors
Main Sequence, Tenmile unsw.edu.au (Checked automatically: the source page says this)
Australian offices
Sydney xylo.bio (Checked automatically: the source page says this)
Website

Each fact links to the public page it came from. Links marked ✓ were verified by our team; the rest were checked automatically against that page. We don't promise every fact is current. Spotted something wrong? Tell us and we'll fix it.

The founders

We name a founder only when a public source we can cite does.

The team 15

We've found 18 people at XYLO on its public pages. These are the roles it publishes; we don't show names. Work here? Claim your profile.

Team

Board and advisors

Each role links to the page XYLO published it on. Is one of these you? Choose “This is me” to claim your profile, or ask us to correct or remove it. Messaging people who've claimed their profile is coming soon.

Open roles 1

  • Chemistry Research Assistant, Sydney (UNSW)

    Research · Sydney

    View roleChecked 11 days ago